During the past decade, Group of companies "Medci" conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Group of companies "Medci"" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Group of companies "Medci"" are "Advanced or Metastatic Esophageal Squamous Cell Carcinoma" (1 trials), "COVID-19 Pneumonia" (1 trials), "Carcinoma, Hepatocellular" (1 trials), "Triple Negative Breast Cancer" (1 trials) and "Unresectable Hepatocellular Carcinoma" (1 trials). Many other conditions were trialed in "Group of companies "Medci"" in a lesser frequency.

Most popular intervention types in "Group of companies "Medci"" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (3 trials), "Bevacizumab" (1 trials), "Cyclophosphamide" (1 trials), "Dose-dense Doxorubicin or dose-dense Epirubicin" (1 trials) and "Lenvatinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Group of companies "Medci"" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Group of companies "Medci"". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Group of companies "Medci", undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Group of companies "Medci", 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".